Leukocyte-rich versus leukocyte-poor platelet-rich plasma for Osteoarthritis: A systematic review
Regenerative Therapy · 2026-03 · 31 · 101078
DOI: 10.1016/j.reth.2026.101078 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Regenerative Therapy, 2026-03. Verfasst von Marta Martín-Vega und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nursing Department, Faculty of Nursing, Physiotherapy and Podiatry, Universidad Complutense de Madrid, 28040, Spain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Osteoarthritis is an increasingly prevalent condition with limited conservative treatments. Platelet-rich plasma (PRP) therapy has gained attention, but its efficacy may depend on the type used. In particular, leukocyte-rich (LR-PRP) and leukocyte-poor (LP-PRP) formulations may influence outcomes, yet direct comparisons are limited. Methodology: a systematic literature search and analysis of clinical trials, through PubMed database, were conducted to evaluate the effect of leukocyte - rich and leukocyte - poor platelet rich plasma in the treatment of osteoarthritis.
Results
11 articles were analyzed individually, including both in vivo and in vitro studies, to examine the effect of leukocytes in PRP.
Conclusion
This review highlights that current evidence is insufficient to determine whether adding leukocytes to PRP provides a clinical benefit in the treatment of osteoarthritis. Overall, results generally show no significant differences between LR-PRP and LP-PRP, suggesting that both may be effective. Although leukocytes were initially thought to induce inflammation, there is no conclusive evidence that local reactions are directly caused by them. Given the limitations of existing studies, further research is required to clarify the role of leukocytes in PRP therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nursing Department, Faculty of Nursing, Physiotherapy and Podiatry, Universidad Complutense de Madrid, 28040, Spain.
- Instituto de Investigación Sanitaria imas12, Grupo Invecuid, 28041, Madrid, Spain.
- Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040, Madrid, Spain.
- Clínica Pododinámica, Madrid, 28005, Spain.
Zitieren
APA
Martín-Vega, M., Gómez-Carrión, Á., Zaragoza-García, I., Ortuño-Soriano, I., Marcelino-Argemi, A., Sanz-Wozniak, P., Saludes-Llamas, R., & Sánchez-Gómez, R. (2026). Leukocyte-rich versus leukocyte-poor platelet-rich plasma for Osteoarthritis: A systematic review. Regenerative Therapy, 31, 101078. https://doi.org/10.1016/j.reth.2026.101078
Vancouver
Martín-Vega M, Gómez-Carrión Á, Zaragoza-García I, Ortuño-Soriano I, Marcelino-Argemi A, Sanz-Wozniak P, et al. Leukocyte-rich versus leukocyte-poor platelet-rich plasma for Osteoarthritis: A systematic review. Regenerative Therapy. 2026;31:101078. doi:10.1016/j.reth.2026.101078
BibTeX
@article{MartnVega2026,
author = {Martín-Vega, Marta and Gómez-Carrión, Álvaro and Zaragoza-García, Ignacio and Ortuño-Soriano, Ismael and Marcelino-Argemi, Arian and Sanz-Wozniak, Paola and Saludes-Llamas, Rebeca and Sánchez-Gómez, Rubén},
title = {Leukocyte-rich versus leukocyte-poor platelet-rich plasma for Osteoarthritis: A systematic review},
journal = {Regenerative Therapy},
year = {2026},
volume = {31},
pages = {101078},
doi = {10.1016/j.reth.2026.101078}
}
EUVIMED